Pacira Biosciences Stock Market Value
| PCRX Stock | USD 21.45 0.28 1.29% |
| Symbol | Pacira |
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Pacira BioSciences. Anticipated expansion of Pacira directly elevates investor willingness to pay premium valuations. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Pacira BioSciences assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Quarterly Earnings Growth (0.48) | Earnings Share 0.46 | Revenue Per Share | Quarterly Revenue Growth 0.065 | Return On Assets |
Understanding Pacira BioSciences requires distinguishing between market price and book value, where the latter reflects Pacira's accounting equity. The concept of intrinsic value - what Pacira BioSciences' is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Market sentiment, economic cycles, and investor behavior can push Pacira BioSciences' price substantially above or below its fundamental value.
It's important to distinguish between Pacira BioSciences' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Pacira BioSciences should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, Pacira BioSciences' trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.
Pacira BioSciences 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Pacira BioSciences' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Pacira BioSciences.
| 11/15/2025 |
| 02/13/2026 |
If you would invest 0.00 in Pacira BioSciences on November 15, 2025 and sell it all today you would earn a total of 0.00 from holding Pacira BioSciences or generate 0.0% return on investment in Pacira BioSciences over 90 days. Pacira BioSciences is related to or competes with Cronos, AnaptysBio, Xencor, Oculis Holding, UroGen Pharma, Kodiak Sciences, and Tandem Diabetes. Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practition... More
Pacira BioSciences Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Pacira BioSciences' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Pacira BioSciences upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.03) | |||
| Maximum Drawdown | 14.2 | |||
| Value At Risk | (6.29) | |||
| Potential Upside | 3.31 |
Pacira BioSciences Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Pacira BioSciences' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Pacira BioSciences' standard deviation. In reality, there are many statistical measures that can use Pacira BioSciences historical prices to predict the future Pacira BioSciences' volatility.| Risk Adjusted Performance | 0.0069 | |||
| Jensen Alpha | (0.07) | |||
| Total Risk Alpha | (0.26) | |||
| Treynor Ratio | (0.01) |
Pacira BioSciences February 13, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0069 | |||
| Market Risk Adjusted Performance | (0) | |||
| Mean Deviation | 2.08 | |||
| Coefficient Of Variation | (341,956) | |||
| Standard Deviation | 2.85 | |||
| Variance | 8.13 | |||
| Information Ratio | (0.03) | |||
| Jensen Alpha | (0.07) | |||
| Total Risk Alpha | (0.26) | |||
| Treynor Ratio | (0.01) | |||
| Maximum Drawdown | 14.2 | |||
| Value At Risk | (6.29) | |||
| Potential Upside | 3.31 | |||
| Skewness | (1.18) | |||
| Kurtosis | 1.9 |
Pacira BioSciences Backtested Returns
Pacira BioSciences maintains Sharpe Ratio (i.e., Efficiency) of -0.0481, which implies the firm had a -0.0481 % return per unit of risk over the last 3 months. Pacira BioSciences exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check Pacira BioSciences' Coefficient Of Variation of (341,956), variance of 8.13, and Risk Adjusted Performance of 0.0069 to confirm the risk estimate we provide. The company holds a Beta of 0.83, which implies possible diversification benefits within a given portfolio. As returns on the market increase, Pacira BioSciences' returns are expected to increase less than the market. However, during the bear market, the loss of holding Pacira BioSciences is expected to be smaller as well. At this point, Pacira BioSciences has a negative expected return of -0.14%. Please make sure to check Pacira BioSciences' mean deviation, treynor ratio, as well as the relationship between the Treynor Ratio and daily balance of power , to decide if Pacira BioSciences performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.64 |
Very good reverse predictability
Pacira BioSciences has very good reverse predictability. Overlapping area represents the amount of predictability between Pacira BioSciences time series from 15th of November 2025 to 30th of December 2025 and 30th of December 2025 to 13th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Pacira BioSciences price movement. The serial correlation of -0.64 indicates that roughly 64.0% of current Pacira BioSciences price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.64 | |
| Spearman Rank Test | -0.5 | |
| Residual Average | 0.0 | |
| Price Variance | 4.71 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Pacira Stock Analysis
When running Pacira BioSciences' price analysis, check to measure Pacira BioSciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pacira BioSciences is operating at the current time. Most of Pacira BioSciences' value examination focuses on studying past and present price action to predict the probability of Pacira BioSciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pacira BioSciences' price. Additionally, you may evaluate how the addition of Pacira BioSciences to your portfolios can decrease your overall portfolio volatility.